» Articles » PMID: 31724031

A Prospective Study on Risk Factors for Olfactory Dysfunction in Aging

Overview
Specialty Geriatrics
Date 2019 Nov 15
PMID 31724031
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Olfactory dysfunction (OD) refers to a reduced or absent ability to smell. OD negatively impacts health and quality of life and its prevalence increases with advancing age. Since OD may be an early marker of dementia and impending death, more knowledge regarding risk factors of OD in aging is warranted. The objective was therefore to explore longitudinally which demographic, genetic, clinical, lifestyle, and cognitive factors predict the development of OD.

Methods: The study included participants aged 60-90 years from the Swedish National Study on Aging and Care in Kungsholmen (SNAC-K), who did not have OD at baseline and were reassessed with an odor identification task at a 6-year follow-up (n = 1,004). Risk factors of OD were assessed with multivariable logistic regression analyses.

Results: The percentage of incident OD cases was 14.2% over 6 years in the total sample and this number increased monotonically with age. Increasing age, carrying the ε4 allele of the APOE gene, atrial fibrillation, cerebrovascular disease, and current smoking were found to be risk factors for the development of OD, whereas better olfactory identification and verbal episodic memory proficiency at baseline were identified as protective factors.

Conclusions: In addition to nonmodifiable factors (age and genetic risk), several modifiable risk factors of OD were identified. This suggests that it might be possible to reduce OD incidence through the management of vascular risk factors and maintenance of a healthy lifestyle.

Citing Articles

Characterizing the olfaction and dementia association in the community-based ARIC study.

Shrestha S, Zhu X, Kucharska-Newton A, Yuan Y, Kamath V, Palta P Alzheimers Dement. 2025; 21(2):e14613.

PMID: 39988999 PMC: 11847982. DOI: 10.1002/alz.14613.


Persistent Post-COVID-19 Olfactory Dysfunction and Its Association with Autonomic Nervous System Function: A Case-Control Study.

Ayoub L, Almarzouki A, Al-Raddadi R, Bendary M Diseases. 2025; 13(1).

PMID: 39851468 PMC: 11765322. DOI: 10.3390/diseases13010004.


Aging-associated sensory decline and Alzheimer's disease.

Hong S, Baek S, Lai M, Arumugam T, Jo D Mol Neurodegener. 2024; 19(1):93.

PMID: 39633396 PMC: 11616278. DOI: 10.1186/s13024-024-00776-y.


Sensory Health Among Older Adults in the United States: A Neighborhood Context Approach.

Goldman A, Pinto J J Gerontol B Psychol Sci Soc Sci. 2024; 79(5.

PMID: 38267366 PMC: 10998359. DOI: 10.1093/geronb/gbae003.


Gray matter and episodic memory associations with olfaction in middle-aged to older adults.

Eckert M, Benitez A, Soler Z, Dubno J, Schlosser R Int Forum Allergy Rhinol. 2023; 14(5):961-971.

PMID: 37897207 PMC: 11045322. DOI: 10.1002/alr.23290.


References
1.
Ekstrom I, Sjolund S, Nordin S, Nordin Adolfsson A, Adolfsson R, Nilsson L . Smell Loss Predicts Mortality Risk Regardless of Dementia Conversion. J Am Geriatr Soc. 2017; 65(6):1238-1243. DOI: 10.1111/jgs.14770. View

2.
Rupp C, Kurz M, Kemmler G, Mair D, Hausmann A, Hinterhuber H . Reduced olfactory sensitivity, discrimination, and identification in patients with alcohol dependence. Alcohol Clin Exp Res. 2003; 27(3):432-9. DOI: 10.1097/01.ALC.0000057945.57330.2C. View

3.
Wehling E, Naess H, Wollschlaeger D, Hofstad H, Bramerson A, Bende M . Olfactory dysfunction in chronic stroke patients. BMC Neurol. 2015; 15:199. PMC: 4604071. DOI: 10.1186/s12883-015-0463-5. View

4.
Liu C, Liu C, Kanekiyo T, Xu H, Bu G . Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat Rev Neurol. 2013; 9(2):106-18. PMC: 3726719. DOI: 10.1038/nrneurol.2012.263. View

5.
Boehme A, Esenwa C, Elkind M . Stroke Risk Factors, Genetics, and Prevention. Circ Res. 2017; 120(3):472-495. PMC: 5321635. DOI: 10.1161/CIRCRESAHA.116.308398. View